Wind-dispelling collateral-activating medicine for demyelinating disease

Abstract

The invention provides a wind-dispelling collateral-activating medicine for the demyelinating disease, belongs to the technical field of medicines, and aims at solving the problem of treating demyelinating disease. The medicine is characterized by being prepared from the following traditional Chinese medicinal materials in parts by mass: 13 parts of uncaria rhynchophylla, 6 parts of apricot kernels, 12 parts of lonicera japonica, 10 parts of dried rehamnnia roots, 10 parts of radix achyranthis bidentatae, 10 parts of silkworm excrement, 12 parts of poria cocos, 10 parts of gastrodia elata, 10 parts of astragalus membranaceus, 10 parts of angelica sinensis, 10 parts of ginseng, 10 parts of cortex phellodendri, 10 parts of rhizoma cibotii, 10 parts of semen cuscutae, 6 parts of safflower carthamus, 9 parts of earthworm, 10 parts of eucommia ulmoides, 10 parts of loranthus parasiticus and 7 parts of licorice roots. The medicine takes wind-toxin invasion, phlegm-heat stagnation and middle-qi deficiency as pathogenesis evidence, is prepared from medicine composition with effects of clearing heat, removing toxicity, tonifying qi, soothing liver, tonifying kidneys, dispelling wind, eliminating phlegm, dredging channels and collaterals and promoting blood circulation to remove stasis as the treatment medicine, and has the advantages of unique and correct theory and remarkable practical curative effect.

Description

technical field [0001] The invention relates to a traditional Chinese medicine for treating demyelinating diseases, and belongs to the field of medical technology. Background technique [0002] Demyelinating disease is an acute or subacute disease that damages the nerve center. The peak of the disease is two to three weeks. If the treatment is delayed and the damaged nerves are secondary to ischemic degeneration, multiple sclerosis will occur. In severe cases, the anterior horn of the spinal cord may be invaded. Cells and brainstem nuclei and pyramidal cells of the cerebral motor cortex are life-threatening, mostly caused by genetic immune abnormalities or viral infections. Early treatment was mostly with hormone and nutritional therapy, but the curative effect was difficult to control. Because the disease caused demyelination and severe neurological damage, secondary axonal damage caused relapse, which further aggravated neurological symptoms and secondary aggravation of th...

AI Technical Summary

Problems solved by technology

The early treatment is mostly with hormone and nutritional therapy, but the curative effect is difficult to control. Because the disease leads to demyelination and severe nerve function damage, secondary axonal damage leads to recurrence, which further aggravates the neurological symptoms and makes the disease worse